Navigation Links
Reprints Desk Survey Highlights Medical Marketers' Key Challenges for Adopting and Using Clinical Reprints in Electronic Format
Date:10/5/2010

SANTA MONICA, Calif., Oct. 5 /PRNewswire/ -- Reprints Desk, Inc. today released the aggregate results of its ePrints Medical Marketing Survey that polled medical marketers, product and brand managers, agency account managers, e-marketing and meeting management professionals, sales management professionals, and executives about their opinions and experiences regarding the procurement and use of reprints of peer-reviewed journal articles.  Survey findings showed that many challenges exist today in the adoption and use of ePrints in areas such as licensing, user experience, technology integration, and pricing.

Participants in the online survey represented companies in pharmaceuticals, biotechnology, medical devices, healthcare communications, marketing services, publishing, and other industries.

Survey results highlights included:

  • For previous usage of more than five scientific journal articles in electronic formats within one or more marketing or sales initiatives:  more than 36% had done so more than once, 5% had done so one time, 30% did not have any experience but were planning to soon, and 29% had no plans to do so.
  • Professionals in Pharmaceuticals and Healthcare Communications generally had the most experience across the various types of marketing activities included in the survey.
  • Website and portals listed ranked as the most popular marketing activities that included ePrint collections, followed by use in customer relationship management (CRM) and in closed-loop marketing (CLM) software, and as a mobile sales aid.
  • More than 50% of respondents indicating that multiple points of contact for licensing, different licensing terms and conditions, varying user experiences, and multiple user agreements were either very or somewhat challenging.

  • "The Reprints Desk Medical Marketing ePrints Survey demonstrates the need for publishers, content aggregators like Reprints Desk, and their shared customers in life sciences to work more closely together to meet the needs of the market," said Scott Ahlberg, Head of Corporate Services at Reprints Desk. "One of our goals in conducting this survey was to benchmark the current state of the ePrints category within the information industry, so we could target our efforts to help publishers distribute more content, to simplify life science companies' ability to use the content  they need, and to ensure that healthcare professionals and consumers have access to the science they need."

    Scientific literature such as scholarly article ePrints are commonly used in the Life Sciences industry in education and promotions, with strict efforts to comply Good Promotional Practices policies and industry guidance such as the Good Reprint Practices guidance issued by the U.S. Food and Drug Administration (FDA).  Results from Reprints Desk's ePrints Medical Marketing Survey were captured from May-July 2010, from a total of 131 respondents.  The survey represented one of the launch activities for Reprints Desk's ePrints NRx scientific licensing and deployment service for websites and portals, physician detailing, customer relationship management systems, and more.

    For more information about Reprints Desk, visit www.reprintsdesk.com. For a complete presentation of results, please contact Reprints Desk or view and download the presentation and survey results at:  http://goo.gl/tb94.  

    About Reprints Desk® Reprints Desk, Inc., a Derycz Scientific subsidiary (OTC Bulletin Board: DYSC), helps companies to obtain and use scientific, technical, and medical (STM) literature in compliance with copyright and Good Promotional Practices.  Services are designed to save time and money, and improve workflows for professionals in information management, research, regulatory affairs, legal, medical affairs, education, sales and marketing. For more information, visit us online at www.reprintsdesk.com. Public and Media Relations Contacts:Ian Palmer, Head of MarketingReprints Desk, Inc. | +1 707.658.1931 ipalmer@reprintsdesk.com
    '/>"/>

    SOURCE Reprints Desk, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. Cubist Pharmaceuticals Becomes First Company to Implement Integrated Reprints Desk Document Delivery and QUOSA Scientific Literature Workflow Solution
    2. UPDATED: Elsevier Online Opinion Survey Reveals Researchers Ready to Push Scientific Search and Discovery to the Next Level
    3. Surveyed European Oncologists Assign Greater Patient Share to Johnson & Johnsons Abiraterone Compared With Other Emerging Therapies in Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer
    4. For Multiple Myeloma Treatment, More Surveyed European Clinicians Consider the Combination of Immunomodulatory Agents and Proteasome Inhibitors Promising With Respect to Efficacy Than Any Other Drug Regimen Combinations
    5. New Global Survey Reveals Over One in Three Patients Fail to Take Insulin as Prescribed
    6. Reportlinker Adds Canadian Dental Market Overview & Dentist Survey 2010 (Implants, Prosthetics, Imaging & CAD/CAM)
    7. National Survey of Physicians Reveals Common Misperceptions Concerning Misuse and Abuse of Opioids in Light of New Government Statistics
    8. Landmark National Survey Conducted by Harris Interactive® Sheds Light on Hidden Problem of Heavy Monthly Periods
    9. Transgenomic Expands Distribution of SURVEYOR® Scan K-RAS Mutation Detection Kit With CE IVD Mark
    10. Survey of Police and Teachers: Alcohol and Marijuana Most Serious Substance Abuse Facing Teens
    11. Survey Reveals Roughly 3 in 5 Women May be Mistreating Their Yeast Infections
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/9/2017)... , May 9, 2017  Oramed Pharmaceuticals Inc. ... a clinical-stage pharmaceutical company focused on the development ... the Canadian Intellectual Property Office has granted Oramed ... Administration of Exenatide". The patent covers Oramed,s invention ... GLP-1 is an incretin hormone that stimulates ...
    (Date:5/6/2017)... 2017  May is Stroke Awareness Month and Omron ... important methods to prevent a stroke: monitor and manage ... Control and Prevention, undetected and uncontrolled hypertension is a ... global leader in personal heart health technology, recently evolved ... attack and stroke and is advancing a national public ...
    (Date:5/4/2017)... and SAN DIEGO , May 4, ... (ACOG) 2017 Annual Clinical and Scientific Meeting— OBP Medical ... medical devices, today announced the launch of a new ... OfficeSPEC and ER-SPEC vaginal specula. Already ... extra-small and extra-large sizes makes OBP Medical,s line of ...
    Breaking Medicine Technology:
    (Date:5/24/2017)... ... ... Myers Jackson is well known for auctioning homes that people move and flip. ... planet. The luxury home market is alive and well and there are mansions for ... “11 Spyglass Hill Auction will enlighten you on the dynamics of how to market ...
    (Date:5/24/2017)... ... May 24, 2017 , ... ... which the endometrial lining of the uterus spreads into the pelvic cavity, ... painful intercourse, painful periods, pelvic pain, or irregular bleeding may have Endometriosis. ...
    (Date:5/24/2017)... ... May 24, 2017 , ... ... to its solutions portfolio. ExtraHop delivers an analytics-first approach, layered with machine learning, ... system, from the datacenter to the cloud to the edge. Through the new ...
    (Date:5/24/2017)... ... May 24, 2017 , ... ... pediatric dentistry options for its patients on Long Island, New York. , ... well being, and is one of the biggest trends in dentistry today. ...
    (Date:5/24/2017)... ... 2017 , ... The CFOs included on this list lead ... the nation and help their organizations navigate the challenges in healthcare today. These ... developing successful hospital and health system strategy. , Becker's Hospital Review has published ...
    Breaking Medicine News(10 mins):